Inebilizumab and Rituximab in Neuromyelitis Optica Spectrum Disorders
Clinical trial NCT06068829 · UNKNOWN
Trial details
- NCT number
- NCT06068829
- Sponsor
- Feng Jinzhou
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2023-10-20
- Primary completion
- 2024-06-30
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.